News

A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer, an aggressive disease subtype that has the poorest outcomes and accounts for as many as one in five cases. The findings are particularly noteworthy because drugs that act on

UC San Francisco is helping to launch a landmark effort by the National Institutes of Health to engage 1 million or more U.S. participants in research aimed at preventing and treating disease based on individual differences in lifestyle, environment and genetics. Four University of California

The following content originally appeared on universityofcalifornia.edu. View the original post. Scientists across the University of California system are taking aim at breast cancer. Along with developing better detection methods, researchers are making advances in imaging techniques and tapping

There’s good news on the breast cancer front: Advances in medicine are helping more women than ever survive a breast cancer diagnosis. Death rates for the disease have been declining for nearly 30 years thanks to better screening and advances in treatment. The survival rate for women diagnosed with

The National Institutes of Health (NIH) has awarded grants to seven UC San Francisco scientists to pursue innovative approaches to major contemporary challenges in biomedical research. The highly competitive grants, which were announced today among 88 such awards nationwide, were made under the High

The UCSF Helen Diller Family Comprehensive Cancer Center is one of only 12 academic centers in the U.S. joining a large national precision medicine study that aims to improve survival for pancreatic cancer patients. The trial, called Precision Promise, is a joint effort between the Pancreatic Cancer

UC San Francisco scientists have engineered human immune cells that can precisely locate diseased cells anywhere in the body and execute a wide range of customizable responses, including the delivery of drugs or other therapeutic payloads directly to tumors or other unhealthy tissues. In experiments